Cargando…

High Expression of FCRLB Predicts Poor Prognosis in Patients With Colorectal Cancer

Background: Mining the prognostic biomarkers of colorectal cancer (CRC) has important clinical and scientific significance. The role of Fc receptor-like B (FCRLB) in solid tumors has never been reported or studied to our knowledge, and the prognostic role of FCRLB in CRC still awaits characterizatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaopeng, Lin, Ruirong, Zeng, Yi, Wang, Yi, Wei, Shenghong, Lin, Zhitao, Chen, Shu, Ye, Zaisheng, Chen, Luchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244534/ https://www.ncbi.nlm.nih.gov/pubmed/35783274 http://dx.doi.org/10.3389/fgene.2022.882307

Ejemplares similares

Corrigendum: Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma
por: Ye, Zaisheng, et al.
Publicado: (2022)

Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma
por: Ye, Zaisheng, et al.
Publicado: (2020)

Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
por: Ye, Zaisheng, et al.
Publicado: (2021)

Prognostic value of preoperative body mass index for diabetic patients with non-metastasis gastric cancer: a single center experience
por: Ye, Zaisheng, et al.
Publicado: (2021)

A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma
por: Ye, Zaisheng, et al.
Publicado: (2021)

FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy
por: Zhou, Xu-jie, et al.
Publicado: (2013)

Increased ATP2A1 Predicts Poor Prognosis in Patients With Colorectal Carcinoma
por: Zhang, Guoshun, et al.
Publicado: (2022)

Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients
por: Li, Zhiyong, et al.
Publicado: (2022)

Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Lin, Xu-tao, et al.
Publicado: (2021)

High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer
por: Chen, Hanxiang, et al.
Publicado: (2022)

Aberrant expression of SPAG6 and NM23 predicts poor prognosis of human osteosarcoma
por: Bao, Zhengqi, et al.
Publicado: (2022)

Downregulation of miR-654-3p in Colorectal Cancer Indicates Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting SRC
por: Zhang, Haoran, et al.
Publicado: (2020)

The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Chen, Liwei, et al.
Publicado: (2023)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
por: Chen, Yao, et al.
Publicado: (2021)

DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
por: Lv, Min-Yi, et al.
Publicado: (2022)

ALK gene amplification is associated with poor prognosis in colorectal carcinoma
por: Bavi, P, et al.
Publicado: (2013)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)

Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs
por: Dai, Yu-yang, et al.
Publicado: (2022)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
por: Ruan, Guo-Tian, et al.
Publicado: (2022)

Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma
por: Zheng, Hongyan, et al.
Publicado: (2022)

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
por: Dai, Siqi, et al.
Publicado: (2020)

Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer
por: Li, Jianxin, et al.
Publicado: (2022)

Enhanced Expression of CNTD2/CCNP Predicts Poor Prognosis in Bladder Cancer Based on the GSE13507
por: Gong, Mancheng, et al.
Publicado: (2021)

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
por: Jiang, Xuefei, et al.
Publicado: (2022)

Apolipoprotein E Overexpression Is Associated With Tumor Progression and Poor Survival in Colorectal Cancer
por: Zhao, Zhixun, et al.
Publicado: (2018)

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022)

The clonal expression genes associated with poor prognosis of liver cancer
por: Zhang, Wanfeng, et al.
Publicado: (2022)

A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma
por: Yan, Lijun, et al.
Publicado: (2022)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
por: Li, Zhiyong, et al.
Publicado: (2022)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma
por: Wang, Luyang, et al.
Publicado: (2022)

A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma
por: Zhou, Yi, et al.
Publicado: (2022)

Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer
por: Li, Cheng-Hang, et al.
Publicado: (2022)

High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia
por: Ren, Zhihong, et al.
Publicado: (2022)

High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration
por: Zhang, Yetao, et al.
Publicado: (2023)

Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer
por: Duan, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctjmvutlmgf1dlb1hamfbsnq45